Our medical review team consists of board certified oncologists/hematologists who are leaders in their respective specialty. As is expected, primary focus is on safety issues that occur during the course of the trial. Equally important is our treatment trend analysis that could affect the overall progress of the respective trial. Rather than working in isolated corporate environs, our medical monitoring teams always include physicians who are active in clinical practice. This provides a key advantage as sponsors benefit from our physicians' closeness to actual patient populations.
